Wednesday, September 9, 2009

MediGene AG Receives Marketing Authorization for Veregen in Germany

September 09, 2009. MediGene AG announces that it has received German marketing authorization for Veregen® for the treatment of genital warts from the Federal Institute for Drugs and Medical Devices

The details can be read here.
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)